REN and Abnormal renal physiology: This analysis did not investigate other factors that influence the progression of renal dysfunction and eGFR slope following ERT, such as the presence of cardiovascular risk factors, the use of renin–angiotensin system (RAS) inhibitors, vitamin D supplements, or of dietary sodium intake, because a large proportion of the concomitant medication data for patients in FOS are missing a finite start date.